UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 276

Sortiert nach

Tumor Vascularization

1, 2020

Link zum Volltext

Verfügbarkeit prüfen

The Anti-VEGF(R) Drug Discovery Legacy: Improving Attrition Rates by Breaking the Vicious Cycle of Angiogenesis in Cancer

Cancers, 2021-07, Vol.13 (14), p.3433

2021

Link zum Volltext

Verfügbarkeit prüfen

Overview on the Different Patterns of Tumor Vascularization

Cells (Basel, Switzerland), 2021-03, Vol.10 (3), p.639

2021

Link zum Volltext

Verfügbarkeit prüfen

Vascular co‐option and vasculogenic mimicry mediate resistance to antiangiogenic strategies

Cancer reports, 2022-12, Vol.5 (12), p.e1318-n/a

2022

Link zum Volltext

Verfügbarkeit prüfen

Vascular Co-Option and Other Alternative Modalities of Growth of Tumor Vasculature in Glioblastoma

Frontiers in oncology, 2022-03, Vol.12, p.874554-874554

2022

Link zum Volltext

Verfügbarkeit prüfen

Editorial: Vascular co-option and beyond for cancer biology

Frontiers in oncology, 2023-06, Vol.13, p.1227540-1227540

2023

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2): an open-label, randomised phase 3 trial

The lancet oncology, 2016-11, Vol.17 (11), p.1543-1557

2016

Link zum Volltext

Verfügbarkeit prüfen

The Role of JMY in p53 Regulation

Cancers, 2018-05, Vol.10 (6), p.173

2018

Link zum Volltext

Verfügbarkeit prüfen

Tertiary lymphoid structure score: a promising approach to refine the TNM staging in resected non-small cell lung cancer

British journal of cancer, 2021-05, Vol.124 (10), p.1680-1689

2021

Link zum Volltext

Verfügbarkeit prüfen

Editorial: Angiogenesis and access to vasculature as a target in gastrointestinal tumors and predictive biomarkers identification: an open challenge

Frontiers in oncology, 2024-05, Vol.14, p.1428174-1428174

2024

Link zum Volltext

Verfügbarkeit prüfen

Vessel co‐option in primary human tumors and metastases: an obstacle to effective anti‐angiogenic treatment?

Cancer medicine (Malden, MA), 2013-08, Vol.2 (4), p.427-436

2013

Link zum Volltext

Verfügbarkeit prüfen

HR23B is a biomarker for tumor sensitivity to HDAC inhibitor-based therapy

Proceedings of the National Academy of Sciences - PNAS, 2010-04, Vol.107 (14), p.6532-6537

2010

Link zum Volltext

Verfügbarkeit prüfen

Comprehensive mutagenesis identifies the peptide repertoire of a p53 T-cell receptor mimic antibody that displays no toxicity in mice transgenic for human HLA-A0201

PloS one, 2021-04, Vol.16 (4), p.e0249967

2021

Link zum Volltext

Verfügbarkeit prüfen

RNA Sequencing Reveals that Kaposi Sarcoma-Associated Herpesvirus Infection Mimics Hypoxia Gene Expression Signature

PLoS pathogens, 2017-01, Vol.13 (1), p.e1006143-e1006143

2017

Link zum Volltext

Verfügbarkeit prüfen

Genome-wide Loss-of-Function Screen Reveals an Important Role for the Proteasome in HDAC Inhibitor-Induced Apoptosis

Cancer cell, 2009-01, Vol.15 (1), p.57-66

2009

Link zum Volltext

Verfügbarkeit prüfen

Impact of microvessel patterns and immune status in NSCLC: a non-angiogenic vasculature is an independent negative prognostic factor in lung adenocarcinoma

Frontiers in oncology, 2023, Vol.13, p.1157461-1157461

2023

Link zum Volltext

Verfügbarkeit prüfen

TRAP1 regulates proliferation, mitochondrial function, and has prognostic significance in NSCLC

Molecular cancer research, 2014-05, Vol.12 (5), p.660-669

2014

Link zum Volltext

Verfügbarkeit prüfen

MicroRNA expression in Sézary syndrome: identification, function, and diagnostic potential

Blood, 2010-08, Vol.116 (7), p.1105-1113

2010

Link zum Volltext

Verfügbarkeit prüfen

Tumor vasculature: a sally port for inhibiting cancer cell spreading

Cancer communications (London, England), 2018-08, Vol.38 (1), p.1-3

2018

Link zum Volltext

Verfügbarkeit prüfen

Proline-hydroxylated hypoxia-inducible factor 1α (HIF-1α) upregulation in human tumours

PloS one, 2014-02, Vol.9 (2), p.e88955-e88955

2014

Link zum Volltext

Verfügbarkeit prüfen

Immunohistological recognition of cyclin D1 expression by non-lymphoid cells among lymphoid neoplastic cells

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2014-03, Vol.122 (3), p.183-191

2014

Link zum Volltext

Verfügbarkeit prüfen

Overexpression of the Oxygen Sensors PHD-1, PHD-2, PHD-3, and FIH Is Associated with Tumor Aggressiveness in Pancreatic Endocrine Tumors

Clinical cancer research, 2008-10, Vol.14 (20), p.6634-6639

2008

Link zum Volltext

Verfügbarkeit prüfen

Next-Generation Sequencing Analysis Reveals Differential Expression Profiles of MiRNA-mRNA Target Pairs in KSHV-Infected Cells

PloS one, 2015-05, Vol.10 (5), p.e0126439-e0126439

2015

Link zum Volltext

Verfügbarkeit prüfen

Tumor necrosis factor receptor-associated protein 1(TRAP1) regulates genes involved in cell cycle and metastases

Cancer letters, 2010-10, Vol.296 (2), p.194-205

2010

Link zum Volltext

Verfügbarkeit prüfen

MicroRNA expression in multiple myeloma is associated with genetic subtype, isotype and survival

Biology direct, 2011-05, Vol.6 (1), p.23-23, Article 23

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 276

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(202)
Mit Volltextzugriff
(247)

Publikationsform

Artikel
(216)
Buchkapitel
(56)
Bücher
(3)
Berichte
(1)

Sprache

Englisch
(276)
Japanisch
(21)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Tumor Vascularization

The Anti-VEGF(R) Drug Discovery Legacy: Improving Attrition Rates by Breaking the Vicious Cycle of Angiogenesis in Cancer

Overview on the Different Patterns of Tumor Vascularization

Vascular co‐option and vasculogenic mimicry mediate resistance to antiangiogenic strategies

Vascular Co-Option and Other Alternative Modalities of Growth of Tumor Vasculature in Glioblastoma

Editorial: Vascular co-option and beyond for cancer biology

Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2): an open-label, randomised phase 3 trial

The Role of JMY in p53 Regulation

Tertiary lymphoid structure score: a promising approach to refine the TNM staging in resected non-small cell lung cancer

Editorial: Angiogenesis and access to vasculature as a target in gastrointestinal tumors and predictive biomarkers identification: an open challenge

Vessel co‐option in primary human tumors and metastases: an obstacle to effective anti‐angiogenic treatment?

HR23B is a biomarker for tumor sensitivity to HDAC inhibitor-based therapy

Comprehensive mutagenesis identifies the peptide repertoire of a p53 T-cell receptor mimic antibody that displays no toxicity in mice transgenic for human HLA-A0201

RNA Sequencing Reveals that Kaposi Sarcoma-Associated Herpesvirus Infection Mimics Hypoxia Gene Expression Signature

Genome-wide Loss-of-Function Screen Reveals an Important Role for the Proteasome in HDAC Inhibitor-Induced Apoptosis

Impact of microvessel patterns and immune status in NSCLC: a non-angiogenic vasculature is an independent negative prognostic factor in lung adenocarcinoma

TRAP1 regulates proliferation, mitochondrial function, and has prognostic significance in NSCLC

MicroRNA expression in Sézary syndrome: identification, function, and diagnostic potential

Tumor vasculature: a sally port for inhibiting cancer cell spreading

Proline-hydroxylated hypoxia-inducible factor 1α (HIF-1α) upregulation in human tumours

Immunohistological recognition of cyclin D1 expression by non-lymphoid cells among lymphoid neoplastic cells

Overexpression of the Oxygen Sensors PHD-1, PHD-2, PHD-3, and FIH Is Associated with Tumor Aggressiveness in Pancreatic Endocrine Tumors

Next-Generation Sequencing Analysis Reveals Differential Expression Profiles of MiRNA-mRNA Target Pairs in KSHV-Infected Cells

Tumor necrosis factor receptor-associated protein 1(TRAP1) regulates genes involved in cell cycle and metastases

MicroRNA expression in multiple myeloma is associated with genetic subtype, isotype and survival

Suchergebnisse filtern